Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil effect on remimazolam ED95 for loss of consciousness
NCT05434494Unknown
- Sponsor
- Ajou University School of Medicine
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of remimazolam in Anesthesia, sponsored by Ajou University School of Medicine. Primary endpoint: 95% Effective Dose for Loss of Consciousness. Status: unknown.
02
Drugs
remimazolam
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT05434494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05434494.